Your browser doesn't support javascript.
loading
Effects of STAT3 polymorphisms and pharmacokinetics on the clinical outcomes of gefitinib treatment in patients with EGFR-mutation positive non-small cell lung cancer.
Yokota, Hayato; Sato, Kazuhiro; Sakamoto, Sho; Okuda, Yuji; Asano, Mariko; Takeda, Masahide; Nakayama, Katsutoshi; Miura, Masatomo.
Afiliação
  • Yokota H; Department of Pharmacy, Akita University Hospital, Akita, Japan.
  • Sato K; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Sakamoto S; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Okuda Y; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Asano M; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Takeda M; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Nakayama K; Division of Respiratory Medicine, Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
  • Miura M; Department of Pharmacy, Akita University Hospital, Akita, Japan.
J Clin Pharm Ther ; 45(4): 652-659, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32402096
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fator de Transcrição STAT3 / Gefitinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Fator de Transcrição STAT3 / Gefitinibe / Neoplasias Pulmonares Idioma: En Ano de publicação: 2020 Tipo de documento: Article